Take-home points: The authors identified two randomized controlled trials evaluating intravenous (IV) albumin for SBP [21-22]. Both trials took place in the university hospital setting comparing IV antibiotics plus albumin infusion to IV antibiotics alone and found a statistically significant reduction in rates of renal failure and in-hospital mortality in the intervention group. This evidence concerns the gene ALB and kidney failure.